Peter Lougheed Centre

Calgary, Alberta T2W 1S7

3 studies enrolling now · 26 studies all time

What they study most

Acute Kidney Injury, Antimicrobial, Arterial Occlusive Diseases, Artery Diseases, Peripheral, Atherosclerosis, Bacteremia, Cardiovascular Diseases, Community-acquired Pneumonia, Influenza, COVID-19, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Connective Tissue Diseases, Critically Ill, Elbow Dislocation

Studies at this site

• A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) — Recruiting now
• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2 — Completed
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — Running, not enrolling
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) — Completed
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension — Completed
• RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty — Completed
• Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial) — Completed
• Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed
• FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH — Status unconfirmed
• Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric — Withdrawn before enrolling
• Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) — Completed
• An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension — Completed
• Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza — Completed
• Study of Ambrisentan in Participants With Pulmonary Hypertension — Completed
• Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 — Stopped early
• Augment® Bone Graft (Formerly GEM OS™1 Bone Graft) Compared to Autologous Bone Graft in Foot and Ankle Fusions — Completed
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) — Stopped early
• Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension — Completed
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures — Completed